从皮损类型、血清标志物和影像学特征评估皮肌炎合并肺间质病变

doi:10.35541/cjd.20220388

中华皮肤科杂志 ›› 2023, e20220388.doi: 10.35541/cjd.20220388

从皮损类型、血清标志物和影像学特征评估皮肌炎合并肺间质病变

叶嘉琪¹,柴维敏²,郑捷¹,曹华¹

¹上海交通大学医学院附属瑞金医院皮肤科，上海 200025；²上海交通大学医学院附属瑞金医院放射科，上海 200025

收稿日期:2022-06-01 修回日期:2023-08-02 发布日期:2023-11-21
通讯作者: 曹华；柴维敏 E-mail:drcaohua@126.com; cwm11394@rjh.com.cn
基金资助:
国家自然科学基金（81573037、81872523、82073432）；国家临床重点专科建设项目（2012649）；上海市科委医学引导类项目（134119a6100）；上海申康医院发展中心临床创新三年行动计划（16CR3084B）；上海交通大学医学院高峰学科——临床医学研究型医师（20172009）；上海市医苑新星青年医学人才培养资助计划杰出青年医学人才类（2019）

Evaluation of dermatomyositis complicated by interstitial lung disease based on skin lesions, serum biomarkers and radiological features

Ye Jiaqi¹, Chai Weimin², Zheng Jie¹, Cao Hua¹

¹Department of Dermatology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China; ²Department of Radiology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China
Corresponding authors: Cao Hua, Email: drcaohua@126.com; Chai Weimin, Email: cwm11394@rjh.com.cn

Received:2022-06-01 Revised:2023-08-02 Published:2023-11-21
Contact: Cao Hua; Chai Weimin E-mail:drcaohua@126.com; cwm11394@rjh.com.cn
Supported by:
National Natural Science Foundation of China （81573037, 81872523, 82073432）; National Key Clinical Specialty （2012649）; Science and Technology Commission of Shanghai Municipality （134119a6100）; Clinical Research Plan of Shanghai Hospital Development Center （16CR3084B）; Shanghai Municipal Education Commission-Gaofeng Clinical Medicine Grant Support （20172009）; Shanghai "Rising Stars of Medical Talent" Youth Development Program Outstanding Youth Medical Talents （2019）

摘要/Abstract

摘要： 【摘要】皮肌炎是一种累及皮肤和肌肉的自身免疫病，还可累及心、肺、关节等脏器或合并恶性肿瘤。在这些并发症中，肺间质病变尤其值得关注，它起病急，因病情进展迅速，早期诊断困难，常导致治疗延误，是皮肌炎患者死亡的常见原因之一。本文从皮损类型、血清标志物及影像学特征来预判皮肌炎合并肺间质病变的风险、严重程度及预后。

关键词: 皮肌炎, 肺疾病, 间质性, 皮肤损害, 血清标志物, 影像学技术

Abstract: 【Abstract】 Dermatomyositis is an autoimmune disease mainly involving the skin and muscles, as well as the heart, lungs, and joints, and it may even be complicated by malignant tumors. Among these complications, interstitial lung disease （ILD） is of particular concern. Because of the urgent onset and rapid progress, ILD is hard to diagnose at the early stage, leading to treatment delay. Furthermore, ILD is the common cause of death in patients with dermatomyositis. This review summarizes types of skin lesions, serum biomarkers and radiological features to evaluate the risk, severity and prognosis of dermatomyositis complicated by ILD.

Key words: Dermatomyositis, Lung disease, interstitial, Skin lesion, Biomarker, Radiological technology

叶嘉琪柴维敏郑捷曹华. 从皮损类型、血清标志物和影像学特征评估皮肌炎合并肺间质病变 [J]. 中华皮肤科杂志, 2023,e20220388. doi:10.35541/cjd.20220388

Ye Jiaqi, Chai Weimin, Zheng Jie, Cao Hua. Evaluation of dermatomyositis complicated by interstitial lung disease based on skin lesions, serum biomarkers and radiological features[J]. Chinese Journal of Dermatology,2023,e20220388. doi:10.35541/cjd.20220388

参考文献 27

［1］	Sun KY, Fan Y, Wang YX, et al. Prevalence of interstitial lung disease in polymyositis and dermatomyositis: a meta⁃analysis from 2000 to 2020［J］. Semin Arthritis Rheum, 2021,51（1）:175⁃191. doi: 10.1016/j.semarthrit.2020.11.009.
［2］	Cao H, Xia Q, Pan M, et al. Gottron papules and gottron sign with ulceration: a distinctive cutaneous feature in a subset of patients with classic dermatomyositis and clinically amyopathic dermatomyositis［J］. J Rheumatol, 2016,43（9）:1735⁃1742. doi: 10.3899/jrheum.160024.
［3］	Irie K, Matsumura N, Hoshi M, et al. Inverse Gottron′s papules in patients with dermatomyositis: an underrecognized but important sign for interstitial lung disease［J］. Int J Dermatol, 2021,60（2）:e62⁃e65. doi: 10.1111/ijd.15204.
［4］	Intapiboon P, Siripaitoon B. Erythematous auricular papules in the fatal cases of anti⁃MDA5 antibody⁃positive interstitial lung disease［J］. Respir Med Case Rep, 2020,31:101299. doi: 10.1016/j.rmcr.2020.101299.
［5］	Nishio M, Endo Y, Kosaka K, et al. Anti⁃aminoacyl⁃tRNA synthetases antibody positive overlap syndrome of systemic sclerosis and dermatomyositis associated with rapidly progressive interstitial lung disease［J］. J Dermatol, 2021,48（2）:e110⁃e111. doi: 10.1111/1346⁃8138.15692.
［6］	Allenbach Y, Uzunhan Y, Toquet S, et al. Different phenotypes in dermatomyositis associated with anti⁃MDA5 antibody: Study of 121 cases［J］. Neurology, 2020,95（1）:e70⁃e78. doi: 10.1212/WNL.0000000000009727.
［7］	Li Y, Li Y, Wu J, et al. Predictors of poor outcome of anti⁃MDA5⁃associated rapidly progressive interstitial lung disease in a Chinese cohort with dermatomyositis［J］. J Immunol Res, 2020,2020:2024869. doi: 10.1155/2020/2024869.
［8］	Cao H, Pan M, Kang Y, et al. Clinical manifestations of dermatomyositis and clinically amyopathic dermatomyositis patients with positive expression of anti⁃melanoma differentiation⁃associated gene 5 antibody［J］. Arthritis Care Res（Hoboken）, 2012,64（10）:1602⁃1610. doi: 10.1002/acr.21728.
［9］	Chen M, Zhao Q, Diao L, et al. Distribution of anti⁃melanoma differentiation associated gene 5（MDA5） IgG subclasses in MDA5+ dermatomyositis［J］. Rheumatology（Oxford）, 2021,61（1）:430⁃439. doi: 10.1093/rheumatology/keab268.
［10］	Xu A, Ye Y, Fu Q, et al. Prognostic values of anti⁃Ro52 antibodies in anti⁃MDA5⁃positive clinically amyopathic dermatomyositis associated with interstitial lung disease［J］. Rheumatology（Oxford）, 2021,60（7）:3343⁃3351. doi: 10.1093/rheumatology/keaa786.
［11］	Gono T, Masui K, Nishina N, et al. Risk prediction modeling based on a combination of initial serum biomarker levels in polymyositis/dermatomyositis⁃associated interstitial lung disease［J］. Arthritis Rheumatol, 2021,73（4）:677⁃686. doi: 10.1002/art.41566.
［12］	Lou Y, Zheng Y, Fan B, et al. Serum levels of interleukins and S100A8/A9 correlate with clinical severity in patients with dermatomyositis⁃associated interstitial lung disease［J］. BMC Pulm Med, 2020,20（1）:196. doi: 10.1186/s12890⁃020⁃01226⁃3.
［13］	Chen M, Quan C, Diao L, et al. Measurement of cytokines and chemokines and association with clinical severity of dermatomyositis and clinically amyopathic dermatomyositis［J］. Br J Dermatol, 2018,179（6）:1334⁃1341. doi: 10.1111/bjd. 17079.
［14］	Matsuda S, Kotani T, Ishida T, et al. Exploration of pathomechanism using comprehensive analysis of serum cytokines in polymyositis/dermatomyositis⁃interstitial lung disease［J］. Rheumatology（Oxford）, 2020,59（2）:310⁃318. doi: 10.1093/rheumatology/kez301.
［15］	Borio G, Terracciano C, Buttafava F, et al. Skin rash and interstitial pneumonia can be a fatal combination: a rare case of anti⁃melanoma differentiation⁃associated gene 5（MDA5）⁃associated interstitial lung disease［J］. Eur J Case Rep Intern Med, 2021,8（10）:002860. doi: 10.12890/2021_002860.
［16］	Palawisuth S, Kantikosum K, Patiyasikunt M, et al. A bad sign: dermatomyositis with interstitial lung disease［J］. Am J Med, 2019,132（2）:182⁃186. doi: 10.1016/j.amjmed.2018.09.013.
［17］	Bai Z, Shen G, Dong L. Analysis of risk factors of interstitial lung disease and mortality rates in Chinese patients with idiopathic inflammatory myopathy［J］. Int J Rheum Dis, 2021,24（6）:815⁃827. doi: 10.1111/1756⁃185X.14128.
［18］	Shen YW, Zhang YM, Huang ZG, et al. Increased levels of soluble CD206 associated with rapidly progressive interstitial lung disease in patients with dermatomyositis［J］. Mediators Inflamm, 2020,2020:7948095. doi: 10.1155/2020/7948095.
［19］	Fujisawa T, Hozumi H, Yasui H, et al. Clinical significance of serum chitotriosidase level in anti⁃MDA5 antibody⁃positive dermatomyositis⁃associated interstitial lung disease［J］. J Rheumatol, 2019,46（8）:935⁃942. doi: 10.3899/jrheum.180825.
［20］	Gao Y, Zhao Q, Xie M, et al. Prognostic evaluation of serum osteopontin in patients with anti⁃MDA5 antibody⁃positive dermatomyositis associated interstitial lung disease［J］. Cytokine, 2020,135:155209. doi: 10.1016/j.cyto.2020.155209.
［21］	Peng QL, Zhang YM, Liang L, et al. A high level of serum neopterin is associated with rapidly progressive interstitial lung disease and reduced survival in dermatomyositis［J］. Clin Exp Immunol, 2020,199（3）:314⁃325. doi: 10.1111/cei.13404.
［22］	Zhu D, Qiao J, Tang S, et al. Elevated carcinoembryonic antigen predicts rapidly progressive interstitial lung disease in clinically amyopathic dermatomyositis［J］. Rheumatology（Oxford）, 2021,60（8）:3896⁃3903. doi: 10.1093/rheumatology/keaa819.
［23］	Wang C, Hou J, Lai J, et al. Correlation between CT score and KL⁃6: a severity assessing in juvenile dermatomyositis associated interstitial lung disease［J］. Can Respir J, 2023,2023:5607473. doi: 10.1155/2023/5607473.
［24］	Xu W, Wu W, Zhang D, et al. A novel CT scoring method predicts the prognosis of interstitial lung disease associated with anti⁃MDA5 positive dermatomyositis［J］. Sci Rep, 2021,11（1）:17070. doi: 10.1038/s41598⁃021⁃96292⁃w.
［25］	Xu W, Wu W, Zheng Y, et al. A Computed tomography radiomics⁃based prediction model on interstitial lung disease in anti⁃MDA5⁃positive dermatomyositis［J］. Front Med（Lausanne）, 2021,8:768052. doi: 10.3389/fmed.2021.768052.
［26］	Cao H, Liang J, Xu D, et al. Radiological characteristics of patients with anti⁃MDA5⁃antibody⁃positive dermatomyositis in（18）F⁃FDG PET/CT: a pilot study［J］. Front Med（Lausanne）, 2021,8:779272. doi: 10.3389/fmed.2021.779272.
［27］	Li J, Wei W, Xu W, et al. ［（68）Ga］Ga⁃FAPI⁃04 and ［（18）F］FDG PET/ CT in a patient with MDA5 dermatomyositis［J］. Eur J Nucl Med Mol Imaging, 2023. doi: 10.1007/s00259⁃023⁃06291⁃4.

[1]	黄晓燕肖易敬丹榕陈明亮沈敏学. 湖南省某砷尾矿地区居民砷中毒皮肤损害患病率及相关因素调查[J]. 中华皮肤科杂志, 2023, 56(7): 636-641.
[2]	湛锦杉玄秀云曹娟梅谌芳琪黄长征. 抗黑素瘤分化相关基因5抗体阳性皮肌炎治疗进展[J]. 中华皮肤科杂志, 2023, 0(2): 20220368-e20220368.
[3]	杨骥徐欣植李明. 皮肌炎的早期诊断和内脏损伤早期识别[J]. 中华皮肤科杂志, 2023, 56(2): 161-164.
[4]	张诗敏胡赟赟赵肖庆杜联军曹华郑捷. 影像技术在皮肌炎诊断和病情评估中的研究进展[J]. 中华皮肤科杂志, 2022, 55(7): 637-640.
[5]	中国医师协会皮肤科医师分会自身免疫病专业委员会 . 【开放获取】环孢素治疗免疫相关性皮肤病专家建议[J]. 中华皮肤科杂志, 2022, 55(6): 471-479.
[6]	吕玲吕小岩. 皮肌炎伴发恶性肿瘤的研究进展[J]. 中华皮肤科杂志, 2022, 55(3): 276-279.
[7]	曹华郑捷. [开放获取] 临床无肌病性皮肌炎诊断标准的演进[J]. 中华皮肤科杂志, 2022, 55(11): 1008-1013.
[8]	中国医疗保健国际交流促进会皮肤科分会国家皮肤与免疫疾病临床医学研究中心. [开放获取] 成人皮肌炎诊疗中国专家共识（2022年）[J]. 中华皮肤科杂志, 2022, 55(11): 939-949.
[9]	杨骥徐欣植李明. 假性血管性水肿：一种新的皮肌炎皮疹[J]. 中华皮肤科杂志, 2022, 55(11): 1019-1020.
[10]	中国医师协会皮肤科医师分会自身免疫性疾病学组. 环磷酰胺治疗自身免疫性皮肤病中国专家共识[J]. 中华皮肤科杂志, 2021, 54(9): 765-770.
[11]	杨骥徐欣植李明. 脂溢性皮炎样皮肌炎：一种特殊类型的皮肌炎[J]. 中华皮肤科杂志, 2021, 54(7): 639-641.
[12]	杨长志张晓萍杨子良周乃慧朱丽萍邵凯朱婷婷余秀琴. 成人皮肌炎患者抗核抗体与临床特征及肿瘤风险的关系[J]. 中华皮肤科杂志, 2021, 54(6): 480-484.
[13]	花玮玮龚春燕. JAK抑制剂在难治性皮肌炎中的应用进展[J]. 中华皮肤科杂志, 2021, 54(3): 264-267.
[14]	中国医师协会皮肤科医师分会自身免疫病专业委员会. 硫唑嘌呤治疗免疫相关性皮肤病专家建议[J]. 中华皮肤科杂志, 2021, 54(2): 116-121.
[15]	中国医师协会皮肤科医师分会自身免疫性疾病专业委员会. 吗替麦考酚酯治疗免疫相关性皮肤病专家建议[J]. 中华皮肤科杂志, 2020, 53(11): 869-874.

从皮损类型、血清标志物和影像学特征评估皮肌炎合并肺间质病变

Evaluation of dermatomyositis complicated by interstitial lung disease based on skin lesions, serum biomarkers and radiological features

PDF

PDF (Mobile)

可视化

摘要/Abstract

引用本文

使用本文

参考文献 27

相关文章 15

Metrics

本文评价

推荐阅读 10